- Home
- APLS vs ALVO Comparison
APLS vs ALVO Comparison
Compare APLS & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ALVO
- Stock Information
- Founded
- APLS 2009
- ALVO 2013
- Country
- APLS United States
- ALVO Luxembourg
- Employees
- APLS N/A
- ALVO N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- APLS Health Care
- ALVO Health Care
- Exchange
- APLS Nasdaq
- ALVO Nasdaq
- Market Cap
- APLS 2.2B
- ALVO 2.5B
- IPO Year
- APLS 2017
- ALVO N/A
- Fundamental
- Price
- APLS $17.69
- ALVO $9.35
- Analyst Decision
- APLS Buy
- ALVO Buy
- Analyst Count
- APLS 19
- ALVO 1
- Target Price
- APLS $37.67
- ALVO $18.00
- AVG Volume (30 Days)
- APLS 2.1M
- ALVO 229.9K
- Earning Date
- APLS 07-31-2025
- ALVO 08-14-2025
- Dividend Yield
- APLS N/A
- ALVO N/A
- EPS Growth
- APLS N/A
- ALVO N/A
- EPS
- APLS N/A
- ALVO 0.34
- Revenue
- APLS $775,839,000.00
- ALVO $587,890,000.00
- Revenue This Year
- APLS $1.01
- ALVO $35.07
- Revenue Next Year
- APLS $22.14
- ALVO $44.61
- P/E Ratio
- APLS N/A
- ALVO $27.70
- Revenue Growth
- APLS 48.04
- ALVO 413.92
- 52 Week Low
- APLS $16.10
- ALVO $7.35
- 52 Week High
- APLS $42.47
- ALVO $13.79
- Technical
- Relative Strength Index (RSI)
- APLS 42.98
- ALVO 41.18
- Support Level
- APLS $18.26
- ALVO $10.32
- Resistance Level
- APLS $19.96
- ALVO $11.85
- Average True Range (ATR)
- APLS 0.84
- ALVO 0.46
- MACD
- APLS -0.08
- ALVO -0.23
- Stochastic Oscillator
- APLS 19.22
- ALVO 19.87
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.